Recursion Pharmaceuticals, Inc. RXRX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s gross profit?
- Recursion Pharmaceuticals, Inc. (RXRX) reported gross profit of -$6.02M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s gross profit changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s gross profit increased by 15.0% year-over-year, from -$7.08M to -$6.02M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s gross profit?
- Over 2 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s gross profit has grown at a -39.5% compound annual growth rate (CAGR), from $10.18M to $3.73M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.